Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma:amulticenter,retrospective analysis
摘要
Dear Editor,Despite the introduction of novel front-line therapies including rituximab plus high-dose cytarabine followed by consolidative autologous stem cell transplantation(ASCT)and salvage therapy with bendamustine,lenalidomide or bortezomib,mantle cell lymphoma(MCL)is still considered incurable and most patients experience relapse or refractory(RR)disease.
基金
Janssen Korea Ltd.provided funding for data collection but was not involved in data analysis and manuscript writing.(Fund number:54179060MCL4008)。
-
1王慧娟,杨光忠,菅原,耿传营,周慧星,陈文明.VRD与VCD方案诱导治疗后序贯自体造血干细胞移植对新诊断的多发性骨髓瘤患者的疗效分析[J].首都医科大学学报,2021,42(4):615-622. 被引量：5
-
2庞艳彬,任杰,范丽霞,李文文,田明杰,罗建民,杜欣.何时应用大剂量阿糖胞苷对急性髓系白血病患者最有利?[J].医学争鸣,2017,8(6):27-30. 被引量：2
-
3Ji-hao ZHOU,Hai-qing LIN,Qi SHEN,Li-na HU,Guo-qiang LI,Xiong-fei SUN,Xin-you ZHANG.Comparison of Mitoxantrone in Combination with Intermediate-dose Cytarabine versus High-dose Cytarabine as Consolidation Therapies for Young Non-APL Acute Myeloid Leukemia Patients with Favorable and Intermediate Cytogenetics[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2018,38(1):51-57. 被引量：2
-
4中华医学会血液学分会浆细胞疾病学组,中国医师协会多发性骨髓瘤专业委员会,黄晓军,吴德沛,李娟,侯健,陈文明,路瑾,蔡真,傅琤琤,刘俊茹.中国多发性骨髓瘤自体造血干细胞移植指南(2021年版)[J].中华血液学杂志,2021,42(5):353-357. 被引量：32
-
5娄安琦,余俊先,程子昭,苏强.布鲁顿氏酪氨酸激酶(BTK)抑制剂与难治性套细胞淋巴瘤[J].中国临床药理学与治疗学,2021,26(6):680-686. 被引量：2
-
6Haige Ye,Aakash Desai,Tiejun Gong,Dongfeng Zeng,Krystle Nomie,Wendy Chen,Wei Wang,Jorge Romaguera,Michael L.Wang.Spontaneous regression of mantle cell lymphoma: a report of four cases[J].Cancer Communications,2018,38(1):329-334. 被引量：1
-
7Siyuan Su,Jianfeng Chen,Ying Wang,Lilly M.Wong,Zhichuan Zhu,Guochun Jiang,Pengda Liu.Lenalidomide downregulates ACE2 protein abundance to alleviate infection by SARS-CoV-2 spike protein conditioned pseudoviruses[J].Signal Transduction and Targeted Therapy,2021,6(6):1664-1667.
-
8曹轶璇,柯鹏,宋通薇.米托蒽醌联合中剂量阿糖胞苷对急性髓系白血病的治疗效果[J].中国医学创新,2021,18(5):125-128. 被引量：1
-
9Sohsuke Meshitsuka,Mitsuo Hori,Shoichi Mitsuhashi,Yasushi Okoshi,Hiroshi Kojima.Reinduction Chemotherapy with Gemtuzumab Ozogamicin and Intermediate/High-Dose Cytarabine: A Single-Center Experience[J].Open Journal of Blood Diseases,2014,4(1):1-8.
-
10Qin WEN,Li GAO,Jing-kang XIONG,Qiong LI,San-bin WANG,Ji-shi WANG,Fang LIU,Cheng ZHANG,Yao LIU,Pei-yan KONG,Xian-gui PENG,Jun RAO,Lei GAO,Xi ZHANG.High-dose Chemotherapy Combined with Autologous Hematopoietic Stem Cell Transplantation as Frontline Therapy for Intermediate/High-risk Diffuse Large B Cell Lymphoma[J].Current Medical Science,2021,41(3):465-473. 被引量：2
